Sadler's Flagstaff Tests Positive for Biphosphonate

|

John Sadler | Horsephotos

By

The John Sadler-trained Flagstaff (Speightstown) tested positive for Clodronic Acid, a bisphosphonate otherwise known as Osphos, after finishing second at Santa Anita Sept. 27 last year, according to a California Horse Racing Board (CHRB) complaint.

As per the complaint, dated Mar. 24, an Osphos positive is a Class 1, Category A penalty. A split sample confirmed the original finding, the complaint states.

Sadler is currently on a year's probation in accordance with a settlement agreement and mutual release with the CHRB, as part of which Sadler was fined $15,000 and handed a 60-day suspension–45 days of which were stayed–for three medication violations dating from 2019.

The suspension ran June 29 through June 13 last year. The year-long probation period ends June 28, 2021.

As stated in the agreement, “If John Sadler violates the terms of his probation, the 45 days of stayed suspension shall be imposed following a noticed hearing.”

Sadler referred the TDN to his attorney, Darrell Vienna, who pointed out that Osphos is listed a Class 1 drug because it's unclassified in California at the moment, but is currently going through the administrative process of being classified a Class 3 medication.

Vienna said that it was his understanding Flagstaff was administered Osphos in late 2019, but that due to an extremely slow rate of elimination in a horse's system–sometimes years–Osphos showed up in last year's test.

“I don't think anything in the report shows any evidence of misfeasance or malfeasance by Sadler,” said Vienna. “This isn't him denying the administration. It's a case of the administration being completely legal at the time. The finding is a result of the pharmacology of the substance, not of any wrongdoing.”

Since the settlement agreement was inked last year, Sadler has been fined $1000 and $1500 accordingly for two positive findings related to timed workouts.

Not a subscriber? Click here to sign up for the daily PDF or alerts.

Exit Box x
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.